C WorldWide Group’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Hold |
|
|||||
|
2025
Q1 | $1.56M | Hold |
|
|||||
|
2024
Q4 | $2.66M | Hold |
|
|||||
|
2024
Q3 | $2.01M | Hold |
|
|||||
|
2024
Q2 | $3.34M | Hold |
|
|||||
|
2024
Q1 | $4.61M | Hold |
|
|||||
|
2023
Q4 | $6.42M | Hold |
|
|||||
|
2023
Q3 | $7.21M | Hold |
|
|||||
|
2023
Q2 | $8.23M | Buy |
|
|||||
|
2023
Q1 | $6.35M | Hold |
|
|||||
|
2022
Q4 | $7.35M | Hold |
|
|||||
|
2022
Q3 | $8.92M | Hold |
|
|||||
|
2022
Q2 | $6.72M | Hold |
|
|||||
|
2022
Q1 | $12M | Hold |
|
|||||
|
2021
Q4 | $14.8M | Hold |
|
|||||
|
2021
Q3 | $14.9M | Sell |
|
|||||
|
2021
Q2 | $14.6M | Hold |
|
|||||
|
2021
Q1 | $15.5M | Hold |
|
|||||
|
2020
Q4 | $18.4M | Hold |
|
|||||
|
2020
Q3 | $19.4M | Buy |
|
|||||
|
2020
Q2 | $16.2M | Hold |
|
|||||
|
2020
Q1 | $14.7M | Buy |
|
|||||
|
2019
Q4 | $14.6M | Hold |
|
|||||
|
2019
Q3 | $16.4M | Buy |
|
|||||
|
2019
Q2 | $15M | Buy |
|
|||||
|
2019
Q1 | $2.71M | Buy |
|
|||||
|
2018
Q4 | $1.54M | Sell |
|
|||||
|
2018
Q3 | $3.76M | Sell |
|
|||||
|
2018
Q2 | $3.74M | Buy |
|
|||||
|
2018
Q1 | $1.91M | Sell |
|
|||||
|
2017
Q4 | $1.76M | Sell |
|
|||||
|
2017
Q3 | $3.19M | Sell |
|
|||||
|
2017
Q2 | $3.47M | Buy |
|
|||||
|
2017
Q1 | $4.08M | Buy |
|
|||||
|
2016
Q4 | $2.67M | Sell |
|
|||||
|
2016
Q3 | $4.2M | Buy |
|
|||||
|
2016
Q2 | $2.55M | Buy |
|
|||||
|
2016
Q1 | $3.15M | Buy |
|
|||||
|
2015
Q4 | $3.35M | Buy |
|
|||||
|
2015
Q3 | $2.48M | Buy |
|
|||||
|
2015
Q2 | $1.73M | Buy |
|